Company record
Empower Clinic Services, LLC dba Empower Pharmacy
3 FDA warning letters since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Empower Clinic Services, LLC dba Empower Pharmacy.
Warning letters
-
DrugsEmpower Clinic Services, LLC dba Empower Pharmacy
FDA warned Empower Pharmacy over unapproved compounded semaglutide/tirzepatide copies and sterile manufacturing deficiencies that put patients at risk.
High risk -
DrugsEmpower Clinic Services, LLC dba Empower Pharmacy
FDA warns Empower Pharmacy that insanitary conditions in sterile drug compounding put patients at risk.
High risk -
DrugsEmpower Clinic Services, LLC dba Empower Pharmacy
FDA warns Empower Pharmacy its compounded drugs missed outsourcing-facility conditions, including labeling and adverse-event reporting.
Medium